HighMark Wealth Management’s MacroGenics MGNX Stock Holding History

HighMark Wealth Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-400	Closed	-$1.16K	–	580
2026 Q1	$1.16K	Hold	400	–	–	﹤0.01%	480
2025 Q4	$644	Hold	400	–	–	﹤0.01%	530
2025 Q3	$672	Hold	400	–	–	﹤0.01%	547
2025 Q2	$484	Hold	400	–	–	﹤0.01%	564
2025 Q1	$508	Hold	400	–	–	﹤0.01%	526
2024 Q4	$1.3K	Hold	400	–	–	﹤0.01%	481
2024 Q3	$1.32K	Hold	400	–	–	﹤0.01%	505
2024 Q2	$1.7K	Hold	400	–	–	﹤0.01%	480
2024 Q1	$5.89K	Hold	400	–	–	﹤0.01%	357
2023 Q4	$3.85K	Hold	400	–	–	﹤0.01%	403
2023 Q3	$1.86K	Hold	400	–	–	﹤0.01%	460
2023 Q2	$2.14K	Hold	400	–	–	﹤0.01%	451
2023 Q1	$2.87K	Hold	400	–	–	﹤0.01%	465
2022 Q4	$2.68K	Hold	400	–	–	﹤0.01%	403
2022 Q3	$1K	Hold	400	–	–	﹤0.01%	482
2022 Q2	$1K	Hold	400	–	–	﹤0.01%	480
2022 Q1	$4K	Hold	400	–	–	﹤0.01%	384
2021 Q4	$6K	Hold	400	–	–	﹤0.01%	344
2021 Q3	$8K	Hold	400	–	–	0.01%	285
2021 Q2	$11K	Hold	400	–	–	0.01%	242
2021 Q1	$13K	Hold	400	–	–	0.01%	204
2020 Q4	$9K	Hold	400	–	–	0.01%	250
2020 Q3	$10K	Hold	400	–	–	0.01%	225
2020 Q2	$11K	Hold	400	–	–	0.01%	185
2020 Q1	$2K	Hold	400	–	–	﹤0.01%	301
2019 Q4	$4K	Buy	+400	New	+$3.96K	﹤0.01%	301

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

HighMark Wealth Management's MGNX Position: Q2 2026 in Review

HighMark Wealth Management sold out of MacroGenics (MGNX) in Q2 2026, closing a stake of 400 shares — an estimated $1.16K sold.

HighMark Wealth Management first reported a position in MGNX in Q4 2019 and held it in 26 quarters. The position peaked at $13K in Q1 2021. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

HighMark Wealth Management reported no remaining MacroGenics position as of Q2 2026 after selling out during the quarter.
HighMark Wealth Management sold 400 MacroGenics shares in Q2 2026, an estimated $1.16K.
HighMark Wealth Management first reported a position in MacroGenics in Q4 2019 and held it in 26 quarters.
HighMark Wealth Management's MacroGenics position peaked at $13K in Q1 2021.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.